Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL286132 | 1.00 | HCAR2 (0.40) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL286130 | 1.00 | HCAR2 (0.40) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL20924835 | 0.82 | NPSR1 (0.46) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL20930482 | 0.76 | HCAR2 (0.44) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL28333073 | 0.76 | HCAR2 (0.39) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL8996514 | 0.74 | HCAR2 (0.37) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL15459193 | 0.71 | — | — | |
| SCHEMBL9461969 | 0.71 | HCAR2 (0.43) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL9461967 | 0.71 | HCAR2 (0.43) | HCAR2KEAP1NFE2L2ALDH1A1 | |
| SCHEMBL9817169 | 0.71 | HCAR2 (0.43) | HCAR2KEAP1NFE2L2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8163728-B2 | Pyrazoles | HOFFMANN-LA ROCHE INC. (US) | 2012-04-24 | — | — | US | disclosed |
| EP-2427455-A1 | ISOXAZOLE-PYRAZOLE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2012-03-14 | — | — | EP | disclosed |
| WO-2010127975-A1 | ISOXAZOLE-PYRAZOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-11-11 | — | — | WO | disclosed |
| US-20100286115-A1 | PYRAZOLES | ROCHE PALO ALTO LLC | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286115-A1 | PYRAZOLES | GABRA5, GABRA1, GABRA3 | HCAR2 202/4885KEAP1 2021/4885NFE2L2 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.